Effect of zinc oxide nanoparticles on neuroblastoma SH-SY5Y cells

被引:1
作者
Zheng, Jinghui [1 ]
Schnurr, Theresia [1 ]
Dunlap, Kriya [1 ,2 ]
Das, Deben [3 ]
Duffy, Lawrence [1 ,2 ]
机构
[1] Department of Chemistry and Biochemistry, University of Alaska Fairbanks, Fairbanks
[2] Institute of Arctic Biology, University of Alaska Fairbanks, Fairbanks
[3] Department of Mechanical Engineering, University of Alaska Fairbanks, Fairbanks
关键词
Nonmaterials; VEGF; ZnO Sh-SY5Y cells;
D O I
10.3844/ajbbsp.2014.116.124
中图分类号
学科分类号
摘要
The Arctic and sub-arctic regions are impacted by the growth of the global nanotechnology industry and the transport of chemicals to the North. New nanotechnology industries, such as neural prothesis, are bringing nanomaterials in direct contact with neurons and glial cells. Nanomaterials have unique chemical and physical properties that may lead to toxicological effects by interfering with normal cellular metabolism. Zinc Oxide Nanoparticles (ZnO NPs) are now very common and widely used in daily life. Over the last decade there have been reports that ZnO NPs can have negative impacts on plants and simple organisms. However, there is a paucity of research on the effects and mechanisms by which ZnO NPs impact neuronal cells. This report investigates how ZnO NPs interact with the neuroblastoma cell line SH-SY5Y. Using transmission electron microscopy, we observed that the ZnO NPs form 36 nm particles, on average and increased the level of the cytokine VEGF in extracellular fluid. Moreover, ZnO NPs, in presence of TNF-α, decreased the level of extracellular VEGF when compared with TNF-α treatment alone. These findings suggest a basis for further studies on the interactions of ZnO NPs with signal transduction pathways and their impact on the release of cytokines. The importance of developing cellular model systems to evaluate the toxicity of nanomaterials before they are released to the marketplace will benefit both the ecosystem and human health. © 2014 Science Publication.
引用
收藏
页码:116 / 124
页数:8
相关论文
共 29 条
[1]  
Bai W., Zhang Z., Tian W., He X., Chai Z., Et al., Toxicity of zinc oxide nanoparticles to zebrafish embryo: A physicochemical study of toxicity mechanism, J. Nanoparticle Res., 12, pp. 1645-1654, (2010)
[2]  
Breier G., Albrecht U., Sterrer S., Risau W., Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation, Development, 114, pp. 521-532, (1992)
[3]  
Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Et al., The potential risks of nanomaterials: A review carried out for ECETOC, Particle Fibre Toxicol., 3, (2006)
[4]  
Boyle J.J., Macrophage activation in atherosclerosis: Pathogenesis and pharmacology of plaque rupture, Curr. Vasc. Pharmacol., 3, pp. 63-68, (2005)
[5]  
Brown L.F., Berse B., Tognazzi K., Manseau E.J., Rosen S., Et al., Vascular permeability factor MRNA and protein expression in human kidney, Kidney Int., 42, pp. 1457-1461, (1992)
[6]  
Brown L.F., Yeo K.T., Berse B., Yeo T.K., van de Water L., Et al., Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing, J. Exp. Med., 176, pp. 1375-1379, (1992)
[7]  
Bruneau A., Fortier M., Gagne F., Gagnon C., Turcotte P., Et al., Size distribution effects of cadmium tellurium quantum dots (CDS/CDTE) immunotoxicity on aquatic organisms, Environ. Sci. Processes Impacts, 15, pp. 596-607, (2013)
[8]  
Buzea C., Pacheco I.I., Robbie K., Nanomaterials and nanoparticles: Sources and toxicity, Biointerphases, (2007)
[9]  
Cao Y., Chen H., Zhou L., Chiang M.K., Anand-Apte B., Et al., Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression and high affinity binding to Flk-1/KDR, J. Biol. Chem., 271, pp. 3154-3162, (1996)
[10]  
De Jong W.H., Borm P.J., Drug delivery and nanoparticles: Applications and hazards, Int. J. Nanomedicine, 3, pp. 133-149, (2008)